SUTRO BIOPHARMA INC (STRO) Stock Cash Flow
NASDAQ:STRO - Nasdaq - US8693671021 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -208.70M | -227.46M | -106.79M | -119.20M | -105.54M | |||
| Depreciation Amortization | 7.47M | 7.22M | 6.82M | 5.69M | 4.84M | |||
| Change In Working Capital | -82.58M | 8.90M | -34.38M | 104.41M | -17.62M | |||
| Interest Paid | 247.00K | 310.00K | 1.13M | 1.87M | 2.05M | |||
| Taxes Paid | 2.37M | 17.52M | 379.00K | 0.00 | 100.00K | |||
| Other non cash items | 34.95M | 19.80M | 22.74M | 12.66M | 36.64M | |||
| OPERATING CASH FLOW | -248.86M | -191.54M | -111.62M | 3.55M | -81.68M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.16M | -3.10M | -4.32M | -7.86M | -15.32M | |||
| Other Investing Activity | 224.26M | 221.61M | 391.00K | -27.16M | -81.99M | |||
| INVESTING CASH FLOW | 221.10M | 218.51M | -3.92M | -35.02M | -97.32M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | -4.08M | -12.50M | -9.38M | 0.00 | |||
| Stock Issued/Repurchased | 1.34M | 98.65M | 12.29M | 58.15M | 2.48M | |||
| Other Financing Activity | -338.00K | -509.00K | 137.77M | -460.00K | 780.00K | |||
| FINANCING CASH FLOW | 999.00K | 94.05M | 137.55M | 48.31M | 3.26M | |||
| CHANGE IN CASH | -26.76M | 121.02M | 22.01M | 16.84M | -175.74M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -248.86M | -191.54M | -111.62M | 3.55M | -81.68M | |||
| Capital Expenditure | -3.16M | -3.10M | -4.32M | -7.86M | -15.32M | |||
| FREE CASH FLOW | -252.02M | -194.64M | -115.93M | -4.31M | -97.00M | |||
All data in USD